Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q3 2024 (September 30)2holders
1new positions
1sold out
1famous investor
$49.44avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($1.8M) and UBS Group AG ($46). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46 |
| Exits | 1 | $78 |
All 13F filers, Q2 2024 → Q3 2024: 40 shares bought and 16 shares sold, net +24 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -0.0% | 36,751 | $1.8M |
| UBS Group AG | — | New | 40 | $46 |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.